Cellectricon Partners with The Automation Partnership
News Dec 04, 2008
Cellectricon has announced the signing of a collaborative agreement with The Automation Partnership (TAP) in the UK, manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications.
Under the agreement TAP will co-develop and manufacture the Dynaflow®HT System, Cellectricon’s next generation high throughput ion channel screening platform. Dynaflow®HT will be launched and commercially available in 2009.
Addressing the limitations of current ion channel screening technologies, the Dynaflow®HT yields a level of automated throughput while still delivering measurement data quality. The concept and technology has been developed and validated over the last three years by Cellectricon in partnership with AstraZeneca.
“We are excited to partner with TAP who are world-renowned for manufacturing industrial quality automation”, says Jonas Ohlsson, CEO at Cellectricon. “To bring this fully automated state-of-the-art high throughput electrophysiology system to the market is a milestone for ion channel screening. The system offers unmatched throughput, cost per data point and reliability/predictability”.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Rapid Test Helps with Administering the "Correct" DrugNews
In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE